Literature DB >> 31509888

Ethnic differences in barriers to symptomatic presentation in primary care: A survey of women in England.

Emily D Williams1, Katriina L Whitaker1, Marianne Piano1, Laura A V Marlow2,3.   

Abstract

OBJECTIVE: The majority of cancers are diagnosed following a decision to access medical help for symptoms. People from ethnic minority backgrounds have longer patient intervals following identification of cancer symptoms. This study quantified ethnic differences in barriers to symptomatic presentation including culturally specific barriers. Correlates of barriers (eg, migration status, health literacy, and fatalism) were also explored.
METHODS: A cross-sectional survey of 720 White British, Caribbean, African, Indian, Pakistani, and Bangladeshi women aged 30 to 60 (n = 120/group) was carried out in England. Barrier items were taken from the widely used cancer awareness measure; additional culturally specific barriers to symptomatic presentation were included following qualitative work (11 barriers in total). Migration status, health literacy, and fatalism were included as correlates to help-seeking barriers.
RESULTS: Ethnic minority women reported a higher number of barriers (P < .001, 2.6-3.8 more than White British women). Emotional barriers were particularly prominent. Women from ethnic minority groups were more likely to report "praying about a symptom" (P < .001, except Bangladeshi women) and "using traditional remedies" (P < .001, except Caribbean women). Among ethnic minority women, adult migration to the United Kingdom, low health literacy, and high fatalistic beliefs increased likelihood of reporting barriers to symptomatic presentation. For example, women who migrated as adults were more likely to be embarrassed (OR = 1.83; CI, 1.06-3.15), worry what the GP might find (OR = 1.91; CI, 1.12-3.26), and be low on body vigilance (OR = 4.44; CI, 2.72-7.23).
CONCLUSIONS: Campaigns addressing barriers to symptomatic presentation among ethnic minority women should be designed to reach low health literacy populations and include messages challenging fatalistic views. These would be valuable for reducing ethnic inequalities in cancer outcomes.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  barriers; cancer; early diagnosis; ethnicity; general practice; symptomatic presentation

Mesh:

Year:  2019        PMID: 31509888     DOI: 10.1002/pon.5225

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  4 in total

1.  Awareness and use of psychosocial care among cancer patients and their relatives-a comparison of people with and without a migration background in Germany.

Authors:  Susanne Singer; Nicola Riccetti; Isabelle Hempler; Marius Fried; Jorge Riera Knorrenschild; Louma Kalie; Martin Merbach; Marcel Reiser; Franz Mosthaf; Vitali Heidt; Kerstin Hermes-Moll
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-11       Impact factor: 4.322

2.  Ethnic inequalities in older adults bowel cancer awareness: findings from a community survey conducted in an ethnically diverse region in England.

Authors:  Robert S Kerrison; Andrew Prentice; Sarah Marshall; Sameer Choglay; Michael Levitan; Marsha Alter; Alex Ghanouni; Lesley McGregor; Christian von Wagner
Journal:  BMC Public Health       Date:  2021-03-16       Impact factor: 3.295

3.  Building the case for the use of gut feelings in cancer referrals: perspectives of patients referred to a non-specific symptoms pathway.

Authors:  Claire Friedemann Smith; Benedikte Møller Kristensen; Rikke Sand Andersen; Sue Ziebland; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2021-12-31       Impact factor: 5.386

4.  Exploring the lived experience of Long Covid in black and minority ethnic groups in the UK: Protocol for qualitative interviews and art-based methods.

Authors:  Nina Smyth; Nisreen A Alwan; Rebecca Band; Ashish Chaudhry; Carolyn A Chew-Graham; Dipesh Gopal; Monique Jackson; Tom Kingstone; Alexa Wright; Damien Ridge
Journal:  PLoS One       Date:  2022-10-03       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.